FDA Permits New Sunscreen Ingredient After 20 Years - Summary - MDSpire

FDA Permits New Sunscreen Ingredient After 20 Years

  • By

  • Kathryn Wighton

  • June 9, 2026

Share

Objective:

To announce the addition of bemotrizinol to the OTC sunscreen monograph.

Key Findings:
  • Bemotrizinol provides protection against both UVA and UVB radiation, as stated by the FDA.
  • It has low systemic absorption following topical use, according to the FDA.
  • The ingredient has been marketed in Europe and other countries prior to U.S. authorization, as noted by the FDA.
Interpretation:

Limitations:
  • The FDA's action does not approve any specific sunscreen product containing bemotrizinol.
Conclusion:

Original Source(s)

FDA Permits New Sunscreen Ingredient After 20 Years

  • by Kathryn Wighton

  • June 9, 2026

Related Content

Biologics Commonly Used in Cutaneous Crohn's Disease

Retrospective multicenter cohort highlights genital-predominant presentation patterns and frequent combination therapy use in cutaneous Crohn's disease.

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.